Helicobacter pylori-related chronic gastritis as a risk factor for colonic neoplasms

World Journal of Gastroenterology

Volumn 20, Issue 6, 2014, Pages 1485-1492

  Inoue, Izumi ^a   Kato, Jun ^a   Tamai, Hideyuki ^a   Iguchi, Mikitaka ^a   Maekita, Takao ^a   Yoshimura, Noriko ^b   Ichinose, Masao ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Atrophic gastritis; Cancer risk; Colorectal neoplasm; Helicobacter pylori antibody; Pepsinogen

Indexed keywords

GASTRIN; IMMUNOGLOBULIN G; PEPSINOGEN;

ACHLORHYDRIA; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CHRONIC GASTRITIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL TUMOR; DISEASE ASSOCIATION; DISEASE COURSE; HELICOBACTER INFECTION; HUMAN; INTESTINE METAPLASIA; MICROSATELLITE INSTABILITY; ANIMAL; BLOOD; CHRONIC DISEASE; COLON TUMOR; COMPLICATION; GASTRITIS; HELICOBACTER PYLORI; INFLAMMATION; MICROBIOLOGY; RISK FACTOR;

ANIMALS; CHRONIC DISEASE; COLONIC NEOPLASMS; DISEASE PROGRESSION; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; PEPSINOGEN A; RISK FACTORS;

EID: 84893799706     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i6.1485     Document Type: Article

References (54)

1. Correa P, Houghton J. Carcinogenesis of Helicobacter pylori. Gastroenterology 2007; 133: 659-672 [PMID: 17681184 DOI: 10.1053/j.gastro.2007.06.026]
2. Konturek SJ, Konturek PC, Pieniazek P, Bielański W. Role of Helicobacter pylori infection in extragastroduodenal disorders: introductory remarks. J Physiol Pharmacol 1999; 50: 683-694 [PMID: 10695551]
3. Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A. Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer 2005; 117: 1058-1059 [PMID: 15986436 DOI: 10.1002/ijc.21280]
4. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A. Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J 2000; 2: 6-9 [PMID: 10892362]
5. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001; 96: 3406-3410 [PMID: 11774957 DOI: 10.1111/ j.1572-0241.2001.05342.x]
6. Fujimori S, Kishida T, Kobayashi T, Sekita Y, Seo T, Nagata K, Tatsuguchi A, Gudis K, Yokoi K, Tanaka N, Yamashita K, Tajiri T, Ohaki Y, Sakamoto C. Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoma, especially in women. J Gastroenterol 2005; 40: 887-893 [PMID: 16211345 DOI: 10.1007/s00535-005-1649-1]
7. Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J. Helicobacter pylori in colorectal neoplasms: is there an aetiological relationship? World J Surg Oncol 2007; 5: 51 [PMID: 17498313 DOI: 10.1186/1477-7819-5-51]
8. Penman ID, el-Omar E, Ardill JE, McGregor JR, Galloway DJ, O'Dwyer PJ, McColl KE. Plasma gastrin concentrations are normal in patients with colorectal neoplasia and unaltered following tumor resection. Gastroenterology 1994; 106: 1263-1270 [PMID: 8174887]
9. Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst 1995; 87: 762-763 [PMID: 7563155 DOI: 10/1093/ jnci/87.10.762]
10. Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, de Franchis R. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 1997; 25: 605-607 [PMID: 9451672 DOI: 10.1097/00004836-199712000-00011]
11. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology 1998; 115: 275-280 [PMID: 9679032 DOI: 10.1016/S0016-5085(98)70193-3]
12. Limburg PJ, Stolzenberg-Solomon RZ, Colbert LH, Perez-Perez GI, Blaser MJ, Taylor PR, Virtamo J, Albanes D. Helicobacter pylori seropositivity and colorectal cancer risk: a prospective study of male smokers. Cancer Epidemiol Biomarkers Prev 2002; 11: 1095-1099 [PMID: 12376513]
13. Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001; 96: 84-88 [PMID: 11197293 DOI: 10.1111/j.1572-0241.2001.03355. x]
14. Machida-Montani A, Sasazuki S, Inoue M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Hanaoka T, Tsugane S. Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study. Helicobacter 2007; 12: 328-332 [PMID: 17669106 DOI: 10.1111/j.1523-5378.2007.00513.x]
15. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a metaanalysis. Helicobacter 2006; 11: 75-80 [PMID: 16579836 DOI: 10.1111/j.1523-5378.2006.00381.x]
16. Zhao YS, Wang F, Chang D, Han B, You DY. Meta-analysis of different test indicators: Helicobacter pylori infection and the risk of colorectal cancer. Int J Colorectal Dis 2008; 23: 875-882 [PMID: 18506454 DOI: 10.1007/s00384-008-0479-z]
17. Inoue I, Mukoubayashi C, Yoshimura N, Niwa T, Deguchi H, Watanabe M, Enomoto S, Maekita T, Ueda K, Iguchi M, Yanaoka K, Tamai H, Arii K, Oka M, Fujishiro M, Takeshita T, Iwane M, Mohara O, Ichinose M. Elevated risk of colorectal adenoma with Helicobacter pylori-related chronic gastritis: a population-based case-control study. Int J Cancer 2011; 129: 2704-2711 [PMID: 21225622 DOI: 10.1002/ijc.25931]
18. Zhang Y, Hoffmeister M, Weck MN, Chang-Claude J, Brenner H. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol 2012; 175: 441-450 [PMID: 22294430 DOI: 10.1093/aje/kwr331]
19. Hong SN, Lee SM, Kim JH, Lee TY, Kim JH, Choe WH, Lee SY, Cheon YK, Sung IK, Park HS, Shim CS. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci 2012; 57: 2184-2194 [PMID: 22669208 DOI: 10.1007/s10620-012-2245-x]
20. Lin YL, Chiang JK, Lin SM, Tseng CE. Helicobacter pylori infection concomitant with metabolic syndrome further increase risk of colorectal adenomas. World J Gastroenterol 2010; 16: 3841-3846 [PMID: 20698048 DOI: 10.3748/wjg.v16. i30.3841]
21. Ciccotosto GD, McLeish A, Hardy KJ, Shulkes A. Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995; 109: 1142-1153 [PMID: 7557079 DOI: 10.1016/0016-5085(95)90572-3]
22. Sessler DI, Rubinstein EH, Moayeri A. Physiologic responses to mild perianesthetic hypothermia in humans. Anesthesiology 1991; 75: 594-610 [PMID: 1928769 DOI: 10.1016/ j.bbrc.2009.02.109]
23. Komine M. Megaloblastic anemia. Int J Hematol 2000; 71 (Suppl 1): 8
24. Lahner E, Sbrozzi-Vanni A, Vannella L, Corleto VD, Di Giulio E, Delle Fave G, Annibale B. No higher risk for colorectal cancer in atrophic gastritis-related hypergastrinemia. Dig Liver Dis 2012; 44: 793-797 [PMID: 22595617 DOI: 10.1016/ j.dld.2012.04.012]
25. Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013; 108: 208-215 [PMID: 23208272 DOI: 10.1038/ajg.2012.407]
26. Laiyemo AO, Kamangar F, Marcus PM, Taylor PR, Virtamo J, Albanes D, Stolzenberg-Solomon RZ. Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control 2010; 21: 163-170 [PMID: 19838812 DOI: 10.1007/ s10552-009-9446-4]
27. Inoue I, Kato J, Yoshimura N, Maeda Y, Moribata K, Shingaki N, Deguchi H, Enomoto S, Maekita T, Ueda K, Iguchi M, Tamai H, Fujishiro M, Yamamichi N, Takeshita T, Ichinose M. Elevated risk of recurrent colorectal neoplasia with Helicobacter pylori-associated chronic atrophic gastritis: a followup study of patients with endoscopically resected colorectal neoplasia. Mol Clin Oncol 2013; 1: 75-82
28. Saini SD, Kim HM, Schoenfeld P. Incidence of advanced adenomas at surveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review. Gastrointest Endosc 2006; 64: 614-626 [PMID: 16996358 DOI: 10.1016/j.gie.2006.06.057]
29. Lin OS. Clinical update: postpolypectomy colonoscopy surveillance. Lancet 2007; 370: 1674-1676 [PMID: 18022025 DOI: 10.1016/S0140-6736(07)61707-3]
30. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-6740 [PMID: 1458460]
31. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, Shimizu Y, Takeshita T, Mohara O, Ichinose M. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004; 109: 138-143 [PMID: 14735480 DOI: 10.1002/ijc.11680]
32. Yanaoka K, Oka M, Mukoubayashi C, Yoshimura N, Enomoto S, Iguchi M, Magari H, Utsunomiya H, Tamai H, Arii K, Ohata H, Fujishiro M, Takeshita T, Mohara O, Ichinose M. Cancer high-risk subjects identified by serum pepsinogen tests: outcomes after 10-year follow-up in asymptomatic middle-aged males. Cancer Epidemiol Biomarkers Prev 2008; 17: 838-845 [PMID: 18398025 DOI: 10.1158/1055-9965. EPI-07-2762]
33. Georgopoulos SD, Polymeros D, Triantafyllou K, Spiliadi C, Mentis A, Karamanolis DG, Ladas SD. Hypergastrinemia is associated with increased risk of distal colon adenomas. Digestion 2006; 74: 42-46 [PMID: 17068397 DOI: 10.1159/000096593]
34. Aly A, Shulkes A, Baldwin GS. Gastrins, cholecystokinins and gastrointestinal cancer. Biochim Biophys Acta 2004; 1704: 1-10 [PMID: 15238241]
35. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995; 61: 3202-3207 [PMID: 7574628]
36. Kado S, Uchida K, Funabashi H, Iwata S, Nagata Y, Ando M, Onoue M, Matsuoka Y, Ohwaki M, Morotomi M. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double-knockout mice. Cancer Res 2001; 61: 2395-2398 [PMID: 11289103]
37. Horie H, Kanazawa K, Okada M, Narushima S, Itoh K, Terada A. Effects of intestinal bacteria on the development of colonic neoplasm: an experimental study. Eur J Cancer Prev 1999; 8: 237-245 [PMID: 10443953 DOI: 10.1097/00008469-199 906000-00012]
38. Howden CW, Hunt RH. Relationship between gastric secretion and infection. Gut 1987; 28: 96-107 [PMID: 3546004 DOI: 10.1136/gut.28.1.96]
39. Drasar BS, Shiner M, McLeod GM. Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology 1969; 56: 71-79 [PMID: 4885396]
40. Thorens J, Froehlich F, Schwizer W, Saraga E, Bille J, Gyr K, Duroux P, Nicolet M, Pignatelli B, Blum AL, Gonvers JJ, Fried M. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 1996; 39: 54-59 [PMID: 8881809 DOI: 10.1136/gut.39.1.54]
41. Evenepoel P, Claus D, Geypens B, Maes B, Hiele M, Rutgeerts P, Ghoos Y. Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy. Aliment Pharmacol Ther 1998; 12: 1011-1019 [PMID: 9798807 DOI: 10.1046/ j.1365-2036.1998.00377.x]
42. Aarbakke J, Schjönsby H. Value of urinary simple phenol and indican determinations in the diagnosis of the stagnant loop syndrome. Scand J Gastroenterol 1976; 11: 409-414 [PMID: 935803]
43. Visek WJ. Diet and cell growth modulation by ammonia. Am J Clin Nutr 1978; 31: S216-S220 [PMID: 707376]
44. Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000; 12: 78-85 [PMID: 10623446 DOI: 10.1006/cyto.1999.0518]
45. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32: 1473-1477 [PMID: 1773951 DOI: 10.1136/gut.32.12.1473]
46. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, Lanyon G, Martin M, Fraumeni JF, Rabkin CS. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402 [PMID: 10746728 DOI: 10.1038/35006081]
47. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42: 227-234 [PMID: 9536948 DOI: 10.1136/gut.42.2.227]
48. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002; 101: 403-408 [PMID: 12216066 DOI: 10.1002/ ijc.10635]
49. Houli N, Loh SW, Giraud AS, Baldwin GS, Shulkes A. Mitogenic effects of both amidated and glycine-extended gastrinreleasing peptide in defunctioned and azoxymethane-treated rat colon in vivo. Regul Pept 2006; 134: 9-16 [PMID: 16297463 DOI: 10.1016/j.regpep.2005.10.001]
50. Malecka-Panas E, Fligiel SE, Jaszewski R, Majumdar AP. Differential responsiveness of proximal and distal colonic mucosa to gastrin. Peptides 1997; 18: 559-565 [PMID: 9210176 DOI: 10.1016/S0196-9781(97)00061-2]
51. Nakajima T, Enomoto S, Ushijima T. DNA methylation: a marker for carcinogen exposure and cancer risk. Environ Health Prev Med 2008; 13: 8-15 [PMID: 19568874 DOI: 10.1007/s12199-007-0005.x]
52. Pereira MA, Wang W, Kramer PM, Tao L. DNA hypomethylation induced by non-genotoxic carcinogens in mouse and rat colon. Cancer Lett 2004; 212: 145-151 [PMID: 15279894 DOI: 10.1016/j.canlet.2004.03.024]
53. Bernstein H, Bernstein C, Payne CM, Dvorakova K, Garewal H. Bile acids as carcinogens in human gastrointestinal cancers. Mutat Res 2005; 589: 47-65 [PMID: 15652226 DOI: 10.1016/j.mrrev.2004.08.001]
54. Giovannucci E, Colditz GA, Stampfer MJ. A meta-analysis of cholecystectomy and risk of colorectal cancer. Gastroenterology 1993; 105: 130-141 [PMID: 8514030]